Category:

Eco/Invest/Demography

IRDAI asks insurers to ensure expeditious settlement of COVID-19 claims

Insurance Regulatory and Development Authority of India (IRDAI) has also requested all the hospitals not to differentiate the patients in terms of admission or treatment.

The regulator noted that there are reports of certain network providers (hospitals) charging high rates and insisting on cash payments from the policyholders for providing treatment to COVID-19 infected patients despite having cashless arrangement with insurers.

read more

Govt issues updated clinical guidance for management of Covid-19 patients

Under emergency use authorisation (EUA), remdesivir may be considered for only those patients with moderate to severe diseases (requiring supplemental oxygen) within 10 days of onset of symptoms.

It is not recommended for those with severe renal impairment or hepatic dysfunction, the guidelines stated.

“Not to be used in patients who are not on oxygen support or in home settings,” the ministry underlined.

read more

Remdesivir production will be up from 38.80 lakh units/month to 74 lakh units/month by May: MHA

“The supply of Remdesivir injection and imported drug Tocilizumab is under severe constraint due to sharp increase in demand. Several steps have been taken to augment the production capacity of the seven licensed manufacturers of Remdesivir injection in the country from 38.80 lakh units per month to 74 lakh units per month by early May 2021,” said Union Home Secretary Ajay Bhalla, in a letter to chief secretaries of all states and Union territories (UTs)

read more

India’s daily COVID-19 cases rise by record 346,786 – health ministry

Ten states, including Maharashtra, Uttar Pradesh, and Delhi, reported 74.15 percent of the new COVID-19 cases reported in a day, the Union health ministry said on Saturday.

“The situation in India is a devastating reminder of what the virus can do,” World Health Organization chief Tedros Adhanom Ghebreyesus told a virtual briefing in Geneva.

read more